Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Overview
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Companies Involved in Therapeutics Development
Eli Lilly and Co
Lin Bioscience Inc
Millennium Pharmaceuticals Inc
NMS Group SpA
Schrodinger LLC
Takeda Pharmaceutical Co Ltd
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Drug Profiles
LBS-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LY-3143921 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MSK-777 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Dormant Products
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Discontinued Products
Cell Division Cycle 7 Related Protein Kise (CDC7 or EC 2.7.11.1) - Product Development Milestones
Featured News & Press Releases
Apr 24, 2018: Lin BioScience Announces FDA Orphan Drug Desigtion for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Aug 23, 2017: Cancer Research UK launches trial to test new drug in patients with advanced cancer
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Top 10 Indications, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020


List of Tables


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Therapy Areas, H1 2020
Number of Products under Development by Indication, H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products under Investigation by Universities/Institutes, H1 2020
Products under Investigation by Universities/Institutes, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Pipeline by Eli Lilly and Co, H1 2020
Pipeline by Lin Bioscience Inc, H1 2020
Pipeline by Millennium Pharmaceuticals Inc, H1 2020
Pipeline by NMS Group SpA, H1 2020
Pipeline by Schrodinger LLC, H1 2020
Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Dormant Projects, H1 2020
Discontinued Products, H1 2020